Cargando…

Bovine Tuberculosis Epidemiology in Cameroon, Central Africa, Based on the Interferon-Gamma Assay

Despite sub-Saharan Africa (SSA) accounting for ~20% of the global cattle population, prevalence estimates and related risk factors of bovine tuberculosis (bTB) are still poorly described. The increased sensitivity of the IFN-γ assay and its practical benefits suggest the test could be useful to inv...

Descripción completa

Detalles Bibliográficos
Autores principales: Kelly, Robert F., Gonzaléz Gordon, Lina, Egbe, Nkongho F., Freeman, Emily J., Mazeri, Stella, Ngwa, Victor N., Tanya, Vincent, Sander, Melissa, Ndip, Lucy, Muwonge, Adrian, Morgan, Kenton L., Handel, Ian G., Bronsvoort, Barend M. D. C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353046/
https://www.ncbi.nlm.nih.gov/pubmed/35937301
http://dx.doi.org/10.3389/fvets.2022.877541
_version_ 1784762788006068224
author Kelly, Robert F.
Gonzaléz Gordon, Lina
Egbe, Nkongho F.
Freeman, Emily J.
Mazeri, Stella
Ngwa, Victor N.
Tanya, Vincent
Sander, Melissa
Ndip, Lucy
Muwonge, Adrian
Morgan, Kenton L.
Handel, Ian G.
Bronsvoort, Barend M. D. C.
author_facet Kelly, Robert F.
Gonzaléz Gordon, Lina
Egbe, Nkongho F.
Freeman, Emily J.
Mazeri, Stella
Ngwa, Victor N.
Tanya, Vincent
Sander, Melissa
Ndip, Lucy
Muwonge, Adrian
Morgan, Kenton L.
Handel, Ian G.
Bronsvoort, Barend M. D. C.
author_sort Kelly, Robert F.
collection PubMed
description Despite sub-Saharan Africa (SSA) accounting for ~20% of the global cattle population, prevalence estimates and related risk factors of bovine tuberculosis (bTB) are still poorly described. The increased sensitivity of the IFN-γ assay and its practical benefits suggest the test could be useful to investigate bTB epidemiology in SSA. This study used a population-based sample to estimate bTB prevalence, identify risk factors and estimate the effective reproductive rate in Cameroonian cattle populations. A cross-sectional study was conducted in the North West Region (NWR) and the Vina Division (VIN) of Cameroon in 2013. A regional stratified sampling frame of pastoral cattle herds produced a sample of 1,448 cattle from 100 herds. In addition, a smaller cross-sectional study sampled 60 dairy cattle from 46 small-holder co-operative dairy farmers in the NWR. Collected blood samples were stimulated with bovine and avian purified protein derivatives, with extracted plasma screened using the IFN-γ enzyme-linked immunosorbent assay (Prionics Bovigam(®)). Design-adjusted population prevalences were estimated, and multivariable mixed-effects logistic regression models using Bayesian inference techniques identified the risk factors for IFN-γ positivity. Using the IFN-γ assay, the prevalence of bTB in the dairy cattle was 21.7% (95% CI: 11.2–32.2). The design-adjusted prevalence of bTB in cattle kept by pastoralists was 11.4% (95% CI: 7.6–17.0) in the NWR and 8.0% (95% CI: 4.7–13.0) in the VIN. A within-herd prevalence estimate for pastoralist cattle also supported that the NWR had higher prevalence herds than the VIN. Additionally, the estimates of the effective reproductive rate R(t) were 1.12 for the NWR and 1.06 for the VIN, suggesting different transmission rates within regional cattle populations in Cameroon. For pastoral cattle, an increased risk of IFN-γ assay positivity was associated with being male (OR = 1.89; 95% CI:1.15–3.09), increasing herd size (OR = 1.02; 95% CI:1.01–1.03), exposure to the bovine leucosis virus (OR = 2.45; 95% CI: 1.19–4.84) and paratuberculosis (OR = 9.01; 95% CI: 4.17–20.08). Decreased odds were associated with contacts at grazing, buffalo (OR = 0.20; 95% CI: 0.03–0.97) and increased contact with other herds [1–5 herds: OR = 0.16 (95% CI: 0.04–0.55); 6+ herds: OR = 0.18 (95% CI: 0.05–0.64)]. Few studies have used the IFN-γ assay to describe bTB epidemiology in SSA. This study highlights the endemic situation of bTB in Cameroon and potential public health risks from dairy herds. Further work is needed to understand the IFN-γ assay performance, particularly in the presence of co-infections, and how this information can be used to develop control strategies in the SSA contexts.
format Online
Article
Text
id pubmed-9353046
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-93530462022-08-06 Bovine Tuberculosis Epidemiology in Cameroon, Central Africa, Based on the Interferon-Gamma Assay Kelly, Robert F. Gonzaléz Gordon, Lina Egbe, Nkongho F. Freeman, Emily J. Mazeri, Stella Ngwa, Victor N. Tanya, Vincent Sander, Melissa Ndip, Lucy Muwonge, Adrian Morgan, Kenton L. Handel, Ian G. Bronsvoort, Barend M. D. C. Front Vet Sci Veterinary Science Despite sub-Saharan Africa (SSA) accounting for ~20% of the global cattle population, prevalence estimates and related risk factors of bovine tuberculosis (bTB) are still poorly described. The increased sensitivity of the IFN-γ assay and its practical benefits suggest the test could be useful to investigate bTB epidemiology in SSA. This study used a population-based sample to estimate bTB prevalence, identify risk factors and estimate the effective reproductive rate in Cameroonian cattle populations. A cross-sectional study was conducted in the North West Region (NWR) and the Vina Division (VIN) of Cameroon in 2013. A regional stratified sampling frame of pastoral cattle herds produced a sample of 1,448 cattle from 100 herds. In addition, a smaller cross-sectional study sampled 60 dairy cattle from 46 small-holder co-operative dairy farmers in the NWR. Collected blood samples were stimulated with bovine and avian purified protein derivatives, with extracted plasma screened using the IFN-γ enzyme-linked immunosorbent assay (Prionics Bovigam(®)). Design-adjusted population prevalences were estimated, and multivariable mixed-effects logistic regression models using Bayesian inference techniques identified the risk factors for IFN-γ positivity. Using the IFN-γ assay, the prevalence of bTB in the dairy cattle was 21.7% (95% CI: 11.2–32.2). The design-adjusted prevalence of bTB in cattle kept by pastoralists was 11.4% (95% CI: 7.6–17.0) in the NWR and 8.0% (95% CI: 4.7–13.0) in the VIN. A within-herd prevalence estimate for pastoralist cattle also supported that the NWR had higher prevalence herds than the VIN. Additionally, the estimates of the effective reproductive rate R(t) were 1.12 for the NWR and 1.06 for the VIN, suggesting different transmission rates within regional cattle populations in Cameroon. For pastoral cattle, an increased risk of IFN-γ assay positivity was associated with being male (OR = 1.89; 95% CI:1.15–3.09), increasing herd size (OR = 1.02; 95% CI:1.01–1.03), exposure to the bovine leucosis virus (OR = 2.45; 95% CI: 1.19–4.84) and paratuberculosis (OR = 9.01; 95% CI: 4.17–20.08). Decreased odds were associated with contacts at grazing, buffalo (OR = 0.20; 95% CI: 0.03–0.97) and increased contact with other herds [1–5 herds: OR = 0.16 (95% CI: 0.04–0.55); 6+ herds: OR = 0.18 (95% CI: 0.05–0.64)]. Few studies have used the IFN-γ assay to describe bTB epidemiology in SSA. This study highlights the endemic situation of bTB in Cameroon and potential public health risks from dairy herds. Further work is needed to understand the IFN-γ assay performance, particularly in the presence of co-infections, and how this information can be used to develop control strategies in the SSA contexts. Frontiers Media S.A. 2022-07-22 /pmc/articles/PMC9353046/ /pubmed/35937301 http://dx.doi.org/10.3389/fvets.2022.877541 Text en Copyright © 2022 Kelly, Gonzaléz Gordon, Egbe, Freeman, Mazeri, Ngwa, Tanya, Sander, Ndip, Muwonge, Morgan, Handel and Bronsvoort. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Veterinary Science
Kelly, Robert F.
Gonzaléz Gordon, Lina
Egbe, Nkongho F.
Freeman, Emily J.
Mazeri, Stella
Ngwa, Victor N.
Tanya, Vincent
Sander, Melissa
Ndip, Lucy
Muwonge, Adrian
Morgan, Kenton L.
Handel, Ian G.
Bronsvoort, Barend M. D. C.
Bovine Tuberculosis Epidemiology in Cameroon, Central Africa, Based on the Interferon-Gamma Assay
title Bovine Tuberculosis Epidemiology in Cameroon, Central Africa, Based on the Interferon-Gamma Assay
title_full Bovine Tuberculosis Epidemiology in Cameroon, Central Africa, Based on the Interferon-Gamma Assay
title_fullStr Bovine Tuberculosis Epidemiology in Cameroon, Central Africa, Based on the Interferon-Gamma Assay
title_full_unstemmed Bovine Tuberculosis Epidemiology in Cameroon, Central Africa, Based on the Interferon-Gamma Assay
title_short Bovine Tuberculosis Epidemiology in Cameroon, Central Africa, Based on the Interferon-Gamma Assay
title_sort bovine tuberculosis epidemiology in cameroon, central africa, based on the interferon-gamma assay
topic Veterinary Science
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353046/
https://www.ncbi.nlm.nih.gov/pubmed/35937301
http://dx.doi.org/10.3389/fvets.2022.877541
work_keys_str_mv AT kellyrobertf bovinetuberculosisepidemiologyincamerooncentralafricabasedontheinterferongammaassay
AT gonzalezgordonlina bovinetuberculosisepidemiologyincamerooncentralafricabasedontheinterferongammaassay
AT egbenkonghof bovinetuberculosisepidemiologyincamerooncentralafricabasedontheinterferongammaassay
AT freemanemilyj bovinetuberculosisepidemiologyincamerooncentralafricabasedontheinterferongammaassay
AT mazeristella bovinetuberculosisepidemiologyincamerooncentralafricabasedontheinterferongammaassay
AT ngwavictorn bovinetuberculosisepidemiologyincamerooncentralafricabasedontheinterferongammaassay
AT tanyavincent bovinetuberculosisepidemiologyincamerooncentralafricabasedontheinterferongammaassay
AT sandermelissa bovinetuberculosisepidemiologyincamerooncentralafricabasedontheinterferongammaassay
AT ndiplucy bovinetuberculosisepidemiologyincamerooncentralafricabasedontheinterferongammaassay
AT muwongeadrian bovinetuberculosisepidemiologyincamerooncentralafricabasedontheinterferongammaassay
AT morgankentonl bovinetuberculosisepidemiologyincamerooncentralafricabasedontheinterferongammaassay
AT handeliang bovinetuberculosisepidemiologyincamerooncentralafricabasedontheinterferongammaassay
AT bronsvoortbarendmdc bovinetuberculosisepidemiologyincamerooncentralafricabasedontheinterferongammaassay